About Odyssea Pharma
Odyssea Pharma is a company based in Grace-hollogne (Belgium) founded in 2008 was acquired by Teva Pharmaceuticals in January 2013. The company has 40 employees as of December 31, 2022. Odyssea Pharma operates in a competitive market with competitors including Pregna, 3Daughters and Femacare, among others.
- Headquarter Grace-hollogne, Belgium
- Employees 40 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Odyssea Pharma
-
Annual Revenue
$40.7 M (USD)-26as on Dec 31, 2022
-
Net Profit
$5.99 M (USD)-50as on Dec 31, 2022
-
EBITDA
$25.46 M (USD)-21as on Dec 31, 2022
-
Latest Funding Round
Not available
- Investors
-
Employee Count
40
as on Dec 31, 2022
-
Acquired by
Teva Pharmaceuticals
(Jan 23, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Odyssea Pharma
Detailed funding history for Odyssea Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Odyssea Pharma
Odyssea Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Teva Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals.
|
Locked | Locked | Locked |
Investor details for Odyssea Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Odyssea Pharma
Investment portfolio details for Odyssea Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Odyssea Pharma
Detailed financials for Odyssea Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Odyssea Pharma Comparisons
Peer comparison for Odyssea Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Odyssea Pharma
Odyssea Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pregna, 3Daughters and Femacare, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Hormonal contraceptives and intrauterine devices are manufactured for reproductive health.
|
|
| Locked | Locked | Locked |
A frameless, magnetic, non-hormonal IUD for long-acting contraception is developed.
|
|
| Locked | Locked | Locked |
Non-hormonal intrauterine devices for women's reproductive health are developed.
|
Detailed competitors of Odyssea Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Odyssea Pharma
Complete news archive for Odyssea Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Odyssea Pharma
Odyssea Pharma was founded in 2008.
Odyssea Pharma is headquartered in Grace-hollogne, Belgium. It is registered at Grace-hollogne, Liege, Belgium.
As of Dec 31, 2022, the latest employee count at Odyssea Pharma is 40.
Annual revenue of Odyssea Pharma is $40.7M as on Dec 31, 2022.
Odyssea Pharma was founded in 2008 as a developer in the womens health sector. Focus is placed on creating the Levosert device, a flexible-frame hormonal intra-uterine system. Levonorgestrel is released steadily into the uterine cavity by this device, offering extended protection against pregnancy. Operations center on pharmaceutical innovation for reproductive health, with a base in Belgium as indicated by the domain. Leadership is provided by Managing Director Christian Cromlin.
Odyssea Pharma's top competitors include Pregna, 3Daughters and Femacare.
Odyssea Pharma has 1 investor. Key investors include Teva Pharmaceuticals.